| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |




*Department of Epidemiology, School of Public Health and Tropical Medicine, and
Department of Medicine, School of Medicine, Tulane University, New Orleans, Louisiana, and
National Heart, Lung, and Blood Institute, Bethesda, Maryland.
Correspondence to Dr. Paul Muntner, Department of Epidemiology, Tulane University SPHTM, 1430 Tulane Avenue, SL-18, New Orleans, LA 70112. Phone: 504-988-1047; Fax: 504-988-1568; E-mail: pmuntner{at}tulane.edu
ABSTRACT. Several epidemiologic studies reported that persons with renal insufficiency might have increased cardiovascular disease-related mortality rates in select populations. The association between renal insufficiency and increased cardiovascular disease-related and all-cause mortality rates during 16 yr of follow-up monitoring was examined among participants who were 30 to 74 yr of age at the baseline examinations in 1976 to 1980, with urinary protein dipstick measurements (n = 8786) or serum creatinine levels of
3.0 mg/dl (n = 6354), from the Second National Health and Nutrition Examination Survey Mortality Study. GFR were estimated by adjusting serum creatinine levels for age, race, and gender, using the Modification of Diet in Renal Disease formula. Cardiovascular disease-related mortality rates were 6.2, 17.9, and 37.2 deaths/1000 person-yr among subjects with urinary protein levels of <30, 30 to 299, and
300 mg/dl and were 4.1, 8.6, and 20.5 deaths/1000 person-yr among participants with estimated GFR of
90, 70 to 89, and <70 ml/min, respectively. After adjustment for potential confounders, the relative hazards (and 95% confidence intervals) for cardiovascular disease-related death were 1.57 (0.99 to 2.48) and 1.77 (0.97 to 3.21) among subjects with urinary protein levels of 30 to 299 and
300 mg/dl, respectively, compared with <30 mg/dl (P trend = 0.02). The corresponding relative hazards for all-cause-related death were 1.64 (1.23 to 2.18) and 2.00 (1.13 to 3.55; P trend < 0.001). Compared with subjects with estimated GFR of
90 ml/min, those with estimated GFR of <70 ml/min exhibited higher relative risks of death from cardiovascular disease and all causes [1.68 (1.33 to 2.13) and 1.51 (1.19 to 1.91), respectively]. This study indicates that, in a representative sample of the United States general population, renal insufficiency is independently associated with increased cardiovascular disease-related and all-cause mortality rates.
This article has been cited by other articles:
![]() |
S. Cottone, G. Mule, M. Guarneri, A. Palermo, M. C. Lorito, R. Riccobene, R. Arsena, F. Vaccaro, A. Vadala, E. Nardi, et al. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients Nephrol. Dial. Transplant., September 4, 2008; (2008) gfn489v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chonchol, H. Gnahn, and D. Sander Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2593 - 2598. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nerpin, U. Riserus, E. Ingelsson, J. Sundstrom, M. Jobs, A. Larsson, S. Basu, and J. Arnlov Insulin Sensitivity Measured With Euglycemic Clamp Is Independently Associated With Glomerular Filtration Rate in a Community-Based Cohort Diabetes Care, August 1, 2008; 31(8): 1550 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hsu, K. L. Johansen, C.-y. Hsu, G. A. Kaysen, and G. M. Chertow Higher Serum Creatinine Concentrations in Black Patients with Chronic Kidney Disease: Beyond Nutritional Status and Body Composition Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 992 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. P. Liew, J. R. Bartholomew, S. Demirjian, J. Michaels, and M. J. Schreiber Jr. Combined Effect of Chronic Kidney Disease and Peripheral Arterial Disease on All-Cause Mortality in a High-Risk Population Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1084 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mehrotra, D. Kermah, L. Fried, S. Adler, and K. Norris Racial Differences in Mortality Among Those with CKD J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1403 - 1410. [Full Text] [PDF] |
||||
![]() |
M. Chonchol, M. Cigolini, and G. Targher Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction Nephrol. Dial. Transplant., January 1, 2008; 23(1): 269 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. DeLoach and R. R. Townsend Vascular Stiffness: Its Measurement and Significance for Epidemiologic and Outcome Studies Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 184 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Orth and S. I. Hallan Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence? Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 226 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Smith, F. A. Masoudi, M. G. Shlipak, H. M. Krumholz, and C. R. Parikh Renal Impairment Predicts Long-Term Mortality Risk after Acute Myocardial Infarction J. Am. Soc. Nephrol., January 1, 2008; 19(1): 141 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Raymond, D. Zehnder, S. C. H. Smith, J. A. Stinson, H. Lehnert, and R. M. Higgins Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3214 - 3220. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sheehan, S.-W. Tsaih, B. L. King, C. Stanton, G. A. Churchill, B. Paigen, and K. DiPetrillo Genetic analysis of albuminuria in a cross between C57BL/6J and DBA/2J mice Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1649 - F1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Glynn, D. Reddan, J. Newell, J. Hinde, B. Buckley, and A. W. Murphy Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2586 - 2594. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rashidi, A. Ghanbarian, and F. Azizi Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 976 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Foley, C. Wang, A. Ishani, and A. J. Collins NHANES III: Influence of Race on GFR Thresholds and Detection of Metabolic Abnormalities J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2575 - 2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Menon, M. G. Shlipak, X. Wang, J. Coresh, T. Greene, L. Stevens, J. W. Kusek, G. J. Beck, A. J. Collins, A. S. Levey, et al. Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease Ann Intern Med, July 3, 2007; 147(1): 19 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakayama, H. Metoki, H. Terawaki, T. Ohkubo, M. Kikuya, T. Sato, K. Nakayama, K. Asayama, R. Inoue, J. Hashimoto, et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--the Ohasama study Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1910 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. B. Nanayakkara, C. van Guldener, P. M. ter Wee, P. G. Scheffer, F. J. van Ittersum, J. W. Twisk, T. Teerlink, W. van Dorp, and C. D. A. Stehouwer Effect of a Treatment Strategy Consisting of Pravastatin, Vitamin E, and Homocysteine Lowering on Carotid Intima-Media Thickness, Endothelial Function, and Renal Function in Patients With Mild to Moderate Chronic Kidney Disease: Results From the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study Arch Intern Med, June 25, 2007; 167(12): 1262 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. White, E. Braunwald, S. A. Murphy, A. J. Jacob, N. Gotcheva, L. Polonetsky, and E. M. Antman Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25 Eur. Heart J., May 1, 2007; 28(9): 1066 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, D. Gu, C.-S. Chen, X. Wu, L. L. Hamm, P. Muntner, V. Batuman, C.-H. Lee, P. K. Whelton, and J. He Association between the metabolic syndrome and chronic kidney disease in Chinese adults Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1100 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wattanakit, A. R. Folsom, E. Selvin, J. Coresh, A. T. Hirsch, and B. D. Weatherley Kidney Function and Risk of Peripheral Arterial Disease: Results from the Atherosclerosis Risk in Communities (ARIC) Study J. Am. Soc. Nephrol., February 1, 2007; 18(2): 629 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mathew, R. J. Lund, F. Strebeck, K. S. Tustison, T. Geurs, and K. A. Hruska Reversal of the Adynamic Bone Disorder and Decreased Vascular Calcification in Chronic Kidney Disease by Sevelamer Carbonate Therapy J. Am. Soc. Nephrol., January 1, 2007; 18(1): 122 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Wannamethee, A. G. Shaper, G. D.O. Lowe, L. Lennon, A. Rumley, and P. H. Whincup Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers Eur. Heart J., December 2, 2006; 27(24): 2975 - 2981. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend The treatment of coronary artery disease in patients with chronic kidney disease QJM, November 1, 2006; 99(11): 723 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors Am J Physiol Renal Physiol, November 1, 2006; 291(5): F932 - F944. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Norris, T. Greene, J. Kopple, J. Lea, J. Lewis, M. Lipkowitz, P. Miller, A. Richardson, S. Rostand, X. Wang, et al. Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2928 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schillaci, M. Pirro, M. R. Mannarino, G. Pucci, G. Savarese, S. S. Franklin, and E. Mannarino Relation Between Renal Function Within the Normal Range and Central and Peripheral Arterial Stiffness in Hypertension Hypertension, October 1, 2006; 48(4): 616 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wattanakit, J. Coresh, P. Muntner, J. Marsh, and A. R. Folsom Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tomiyama, A. Higa, M. A. Dalboni, M. Cendoroglo, S. A. Draibe, L. Cuppari, A. B. Carvalho, E. M. Neto, and M. E. F. Canziani The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2464 - 2471. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Sarafidis and G. L. Bakris Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2366 - 2374. [Full Text] [PDF] |
||||
![]() |
L. Zhang, L. Zuo, F. Wang, M. Wang, S. Wang, J. Lv, L. Liu, and H. Wang Cardiovascular Disease in Early Stages of Chronic Kidney Disease in a Chinese Population J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2617 - 2621. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Volkova, W. McClellan, J. M. Soucie, and A. Schoolwerth Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2202 - 2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Monk and D. A. Bennett Reno-cerebrovascular disease? The incognito kidney in cognition and stroke. Neurology, July 25, 2006; 67(2): 196 - 198. [Full Text] [PDF] |
||||
![]() |
E. S. Ommen, J. A. Winston, and B. Murphy Medical Risks in Living Kidney Donors: Absence of Proof Is Not Proof of Absence Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 885 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, N. Wiebe, B. Culleton, A. House, C. Rabbat, M. Fok, F. McAlister, and A. X. Garg Chronic Kidney Disease and Mortality Risk: A Systematic Review J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2034 - 2047. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Nguyen and A. G. Stack Ethnic Disparities in Cardiovascular Risk Factors and Coronary Disease Prevalence among Individuals with Chronic Kidney Disease: Findings from the Third National Health and Nutrition Examination Survey J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1716 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Hemmelgarn, D. A. Southern, K. H. Humphries, B. F. Culleton, M. L. Knudtson, W. A. Ghali, and for the Alberta Provincial Project for Outcomes As Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization Eur. Heart J., May 2, 2006; 27(10): 1191 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Meisinger, A. Doring, H. Lowel, and for the KORA Study Group Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population Eur. Heart J., May 2, 2006; 27(10): 1245 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iseki Screening for renal disease--what can be learned from the Okinawa experience Nephrol. Dial. Transplant., April 1, 2006; 21(4): 839 - 843. [Full Text] [PDF] |
||||
![]() |
R. Yamamoto and Y. Aso Synergistic Association of Metabolic Syndrome and Overt Nephropathy With Elevated Asymmetric Dimethylarginine in Serum and Impaired Cutaneous Microvasodilation in Patients With Type 2 Diabetes Diabetes Care, April 1, 2006; 29(4): 928 - 930. [Full Text] [PDF] |
||||
![]() |
G. D'Amico Statins and Renal Diseases: From Primary Prevention to Renal Replacement Therapy. J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S148 - S152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. O'Hare, D. Bertenthal, K. E. Covinsky, C. S. Landefeld, S. Sen, K. Mehta, M. A. Steinman, A. Borzecki, and L. C. Walter Mortality Risk Stratification in Chronic Kidney Disease: One Size for All Ages? J. Am. Soc. Nephrol., March 1, 2006; 17(3): 846 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Sarafidis and G. L. Bakris Level of Kidney Function Determines Cardiovascular Fate After Coronary Bypass Graft Surgery Circulation, February 28, 2006; 113(8): 1046 - 1047. [Full Text] [PDF] |
||||
![]() |
G. S. Hillis, B. L. Croal, K. G. Buchan, H. El-Shafei, G. Gibson, R. R. Jeffrey, C. G.M. Millar, G. J. Prescott, and B. H. Cuthbertson Renal Function and Outcome From Coronary Artery Bypass Grafting: Impact on Mortality After a 2.3-Year Follow-Up Circulation, February 28, 2006; 113(8): 1056 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rahman, S. Pressel, B. R. Davis, C. Nwachuku, J. T. Wright Jr., P. K. Whelton, J. Barzilay, V. Batuman, J. H. Eckfeldt, M. A. Farber, et al. Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration Rate Ann Intern Med, February 7, 2006; 144(3): 172 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Cosmo, R. Trevisan, A. Minenna, M. Vedovato, R. Viti, S. A. Santini, A. R. Dodesini, P. Fioretto, and V. Trischitta Insulin Resistance and the Cluster of Abnormalities Related to the Metabolic Syndrome Are Associated With Reduced Glomerular Filtration Rate in Patients With Type 2 Diabetes Diabetes Care, February 1, 2006; 29(2): 432 - 434. [Full Text] [PDF] |
||||
![]() |
Y. Maaravi, M. Bursztyn, R. Hammerman-Rozenberg, A. Cohen, and J. Stessman Moderate renal insufficiency at 70 years predicts mortality QJM, February 1, 2006; 99(2): 97 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Leeder, P. Mitchell, G. Liew, E. Rochtchina, W. Smith, and J. J. Wang Low Hemoglobin, Chronic Kidney Disease, and Risk for Coronary Heart Disease-Related Death: The Blue Mountains Eye Study J. Am. Soc. Nephrol., January 1, 2006; 17(1): 279 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Jee, L. E. Boulware, E. Guallar, I. Suh, L. J. Appel, and E. R. Miller III Direct, Progressive Association of Cardiovascular Risk Factors With Incident Proteinuria: Results From the Korea Medical Insurance Corporation (KMIC) Study Arch Intern Med, October 24, 2005; 165(19): 2299 - 2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Reddan, L. Szczech, M. V. Bhapkar, D. J. Moliterno, R. M. Califf, E. M. Ohman, P. B. Berger, J. S. Hochman, F. Van de Werf, R. A. Harrington, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2105 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gil, S. Justo, and C. Caramelo Cardio-renal failure: an emerging clinical entity Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1780 - 1783. [Full Text] [PDF] |
||||
![]() |
A. M. O'Hare, R. A. Rodriguez, and P. Bacchetti Low Ankle-Brachial Index Associated With Rise in Creatinine Level Over Time: Results From the Atherosclerosis Risk in Communities Study Arch Intern Med, July 11, 2005; 165(13): 1481 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox) Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Weiner, H. Tighiouart, P. T. Vlagopoulos, J. L. Griffith, D. N. Salem, A. S. Levey, and M. J. Sarnak Effects of Anemia and Left Ventricular Hypertrophy on Cardiovascular Disease in Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1803 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Davies, Richard. J. Lund, S. Mathew, and K. A. Hruska Low Turnover Osteodystrophy and Vascular Calcification Are Amenable to Skeletal Anabolism in an Animal Model of Chronic Kidney Disease and the Metabolic Syndrome J. Am. Soc. Nephrol., April 1, 2005; 16(4): 917 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Foley, A. M. Murray, S. Li, C. A. Herzog, A. M. McBean, P. W. Eggers, and A. J. Collins Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999 J. Am. Soc. Nephrol., February 1, 2005; 16(2): 489 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Muntner, J. He, B. C. Astor, A. R. Folsom, and J. Coresh Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease: Results from the Atherosclerosis Risk in Communities Study J. Am. Soc. Nephrol., February 1, 2005; 16(2): 529 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam The severe cardiorenal syndrome: 'Guyton revisited' Eur. Heart J., January 1, 2005; 26(1): 11 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jernberg, B. Lindahl, S. James, A. Larsson, L.-O. Hansson, and L. Wallentin Cystatin C: A Novel Predictor of Outcome in Suspected or Confirmed Non-ST-Elevation Acute Coronary Syndrome Circulation, October 19, 2004; 110(16): 2342 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-y. Hsu Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization N. Engl. J. Med., September 23, 2004; 351(13): 1296 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Akbari, P. J. Swedko, H. D. Clark, W. Hogg, J. Lemelin, P. Magner, L. Moore, an |